Skip to main content
. 2021 Jul 27;26:e00251. doi: 10.1016/j.plabm.2021.e00251

Table 2.

Accuracy study using DEQAS samples.

Target (ng/mL) DiaSorin
Elecsys
Lumipulse
25(OH)D (ng/mL) Bias (%) 25(OH)D (ng/mL) Bias (%) 25(OH)D (ng/mL) Bias (%)
DEQAS 561 26.6 29.2 9.8 30.0 12.8 22.1 −16.9
DEQAS 562 19.2 21.0 9.6 19.6 2.5 13.6 −29.0
DEQAS 563 35.5 34.9 −1.7 41.2 16.0 31.1 −12.7
DEQAS 564 17.4 19.4 11.8 18.8 8.3 13.3 −23.8
DEQAS 565 30.5 35.1 15.1 30.8 0.9 26.4 −13.5
DEQAS 566 27.4 25.2 −7.9 30.4 11.0 22.7 −16.9
DEQAS 567 26.8 25.6 −4.6 30.8 15.0 23.3 −13.1
DEQAS 568 12.7 12.6 −0.6 15.8 24.9 9.2 −27.0
DEQAS 569 33.0 35.0 5.9 38.4 16.2 29.8 −9.8
DEQAS 570 54.0 54.8 1.5 65.6 21.5 50.3 −6.8
Mean 3.9 12.9 −16.9
SD 7.6 7.6 7.4

DEQAS, Vitamin D External Quality Assurance Scheme, bias (%) = [(method – target)/target] x 100. Samples 561–565 belong to the DEQAS October 2019 exercise and samples 566–570 were from the DEQAS January 2020 exercise.